Clinical trials
Phase 2 Liposarcoma trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
43 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 2 |
| 2006 | 3 |
| 2007 | 2 |
| 2008 | 1 |
| 2010 | 2 |
| 2012 | 4 |
| 2014 | 1 |
| 2015 | 4 |
| 2016 | 3 |
| 2017 | 2 |
| 2019 | 3 |
| 2020 | 3 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 3 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 24 |
| Active, not recruiting | 9 |
| Terminated | 4 |
| Withdrawn | 3 |
| Recruiting | 2 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 7 |
| Memorial Sloan Kettering Cancer Center | 6 |
| Dana-Farber Cancer Institute | 3 |
| Alliance for Clinical Trials in Oncology | 2 |
| Brown University | 2 |
| Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2 |
| M.D. Anderson Cancer Center | 2 |
| Pfizer | 2 |
| Alexander Z. Wei, MD | 1 |
| Benjamin Izar | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Liposarcoma | 43 |
| Sarcoma | 30 |
| Leiomyosarcoma | 19 |
| Histiocytoma, Malignant Fibrous | 15 |
| Hemangiosarcoma | 12 |
| Fibrosarcoma | 10 |
| Sarcoma, Synovial | 10 |
| Rhabdomyosarcoma | 9 |
| Dermatofibrosarcoma | 7 |
| Osteosarcoma | 7 |
Trials
Showing 1 to 25 of 43. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.